Comparison of three methods for genotyping the UGT1A1 (TA)n repeat polymorphism

被引:24
作者
Baudhuin, Linnea M. [1 ]
Highsmith, W. Edward [1 ]
Skierka, Jennifer [1 ]
Holtegaard, Leonard [1 ]
Moore, Brenda E. [1 ]
O'Kane, Dennis J. [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Rochester, MN 55905 USA
关键词
capillary electrophoresis; fragment analysis; genotyping; irinotecan; sequencing; TATA box; UGT1A1;
D O I
10.1016/j.clinbiochem.2007.03.007
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: The UGT1A1 promoter contains a (TA)(n) repeat polymorphism. The 7 repeat allele is associated with decreased enzyme activity and patients homozygous for this allele treated with irinotecan may experience life-threatening toxicity. Here, we have compared three methods [DNA sequencing, fragment analysis, and the Invader (R) assay (Third Wave Technologies)] for genotyping this polymorphism. Results: All of the DNA samples (n = 119) had concordant genotype calls between the sequencing and size-based methods. The Invader (R) method was also concordant if the genotypes were 6/6, 6/7, or 7/7. Both the size-based method and the Invader (R) method had straightforward data analysis, while interpretation of the sequencing results was occasionally more challenging. The Invader (R) method required more concentrated DNA for analysis, was more expensive, and had a limited genotyping spectrum. Conclusion: All three methods were valuable for genotyping the UGT1A1 (TA)(n) repeat, with the sequencing and size-based assays having the fewest drawbacks. C 2007 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:710 / 717
页数:8
相关论文
共 34 条
[1]  
Akaba K, 1998, BIOCHEM MOL BIOL INT, V46, P21
[2]   The UGT1A1*28 allele is relatively rare in a Japanese population [J].
Ando, Y ;
Chida, M ;
Nakayama, K ;
Saka, H ;
Kamataki, T .
PHARMACOGENETICS, 1998, 8 (04) :357-360
[3]  
Ando Y, 2000, CANCER RES, V60, P6921
[4]   Polymorphisms of UDP-glucuronosyltransferase and pharmacokinetics of irinotecan [J].
Ando, Y ;
Ueoka, H ;
Sugiyama, T ;
Ichiki, M ;
Shimokata, K ;
Hasegawa, Y .
THERAPEUTIC DRUG MONITORING, 2002, 24 (01) :111-116
[5]   ANALYSIS OF GENES FOR BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE IN GILBERTS-SYNDROME [J].
AONO, S ;
ADACHI, Y ;
UYAMA, E ;
YAMADA, Y ;
KEINO, H ;
NANNO, T ;
KOIWAI, O ;
SATO, H .
LANCET, 1995, 345 (8955) :958-959
[6]   Genotyping by "cold single-strand conformation polymorphism" of the UGT1A1 promoter polymorphism in Mexican mestizos [J].
Arámbula, E ;
Vaca, G .
BLOOD CELLS MOLECULES AND DISEASES, 2002, 28 (01) :86-90
[7]   Genetic polymorphisms of UDP-glucuronosyltransferase in Asians:: UGT1A1*28 is a common allele in Indians [J].
Balram, C ;
Sabapathy, K ;
Fei, G ;
Khoo, KS ;
Lee, EJD .
PHARMACOGENETICS, 2002, 12 (01) :81-83
[8]   Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter:: A balanced polymorphism for regulation of bilirubin metabolism? [J].
Beutler, E ;
Gelbart, T ;
Demina, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) :8170-8174
[9]  
Biondi ML, 1999, CLIN CHEM, V45, P897
[10]   Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects [J].
Borlak, J ;
Thum, T ;
Landt, O ;
Erb, K ;
Hermann, R .
HEPATOLOGY, 2000, 32 (04) :792-795